Tuberculosis after a borderline QuantiFERON result during screening before infliximab

Jonathan W. Uzorka, Nathalie M. Delfos, Anne M.C. Witte, Henk Scheper, Dick van Soolingen, Sandra M. Arend

Source: Eur Respir J, 52 (2) 1800913; 10.1183/13993003.00913-2018
Journal Issue: August
Disease area: Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jonathan W. Uzorka, Nathalie M. Delfos, Anne M.C. Witte, Henk Scheper, Dick van Soolingen, Sandra M. Arend. Tuberculosis after a borderline QuantiFERON result during screening before infliximab. Eur Respir J, 52 (2) 1800913; 10.1183/13993003.00913-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
QuantiFERON-TB Gold in-tube test for diagnosis of latent tuberculosis (TB) infection among immunocompromised adults
Source: Annual Congress 2013 –Immunological diagnosis of tuberculosis and latent tuberculosis infection
Year: 2013



Indeterminate results of the quantiFERON®TB gold (QFT) in hospitalized patients at risk for MTB infection/disease
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008

Frequency and significance of indeterminate and borderline Quantiferon Gold TB IGRA results
Source: Eur Respir J, 50 (4) 1701267; 10.1183/13993003.01267-2017
Year: 2017



Comparison of the accuracy of QuantiFERON TB gold in tube vs QuantiFERON-TB plus
Source: International Congress 2016 – Active and latent tuberculosis: biomarkers
Year: 2016

Xpert MTB/RIF testing of pooled induced sputum
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014

QuantiFERON®-TB or QFT in sarcoidosis
Source: Annual Congress 2008 - Clinical aspects in the management of sarcoidosis
Year: 2008


Sensitivity of the QuantiFERON-TB Gold test in culture-verified NTM disease and TB in a Danish setting
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012


Influence of early diagnostics with Xpert MTB/RIF on MDR TB patients treatment efficacy
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015

Evaluation of QuantiFERON TB test (QFT-TB) in detection of children infected with mycobacterium tuberculosis
Source: Annual Congress 2009 - From bench to bedside: diagnosis of tuberculosis
Year: 2009


Comparative results of skin testing using tuberculosis allergen recombinant (CFP-10-ESAT-6) and QuantiFERON – GIT in children and adolescents with TB infection
Source: International Congress 2014 – Tuberculosis: diagnosis
Year: 2014


Diagnosis of latent tuberculosis infection (LTBI) by quantiFERON®-TB gold test – QFT in homeless people in Poland
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008

The effect of smoking on QuantiFERON results in diagnosis of latent tuberculosis infection
Source: International Congress 2016 – Latent tuberculosis infection
Year: 2016


Low real-world utility of IGRA when screening for LTBI in a low incidence setting
Source: International Congress 2015 – Screening strategies in TB
Year: 2015


Tuberculin skin testing to the IGRA positive contacts of infectious tuberculosis cases for the treatment of latent tuberculosis infection
Source: International Congress 2015 – Latent TB infection and screening
Year: 2015


Effects of corticosteroid treatment on the performance of QuantiFERON Gold In-Tube test in the diagnosis of latent tuberculosis infection
Source: Annual Congress 2010 - Immune responses for the diagnosis of tuberculosis
Year: 2010


Evaluation of IP-10 in IGRA for LTBI diagnosis
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018



Role of GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampacin(R) resistance in patients in high risk DRTB
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Estimation of the role of the test GeneXpert MTB-RIF in the diagnosis of pulmonary tuberculosis
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014

Are there any similarities between the skin and the blood tests with CFP10-ESAT6 in tuberculosis patients?
Source: Annual Congress 2013 –Diagnostic features of tuberculosis II
Year: 2013

Diagnostic efficiency of quantiferon TB gold test in the diagnosis of tuberculous pleurisy
Source: Annual Congress 2010 - Extrapulmonary tuberculosis
Year: 2010